|
| 2006 Annual Index |
|
| January 2; 48 (1225) : 1-4 |
| Statins for High-Risk Patients without Heart Disease or High Cholesterol; |
| A Combination of Oxycodone and Ibuprofen (Combunox) for Pain |
|
| January 16; 48 (1226) : 5-8 |
| Adacel and Boostrix: Tdap Vaccines for Adolescents and Adults; |
| Drugs in the Elderly; |
| Chromium Supplementation |
|
| January 30; 48 (1227) : 9-12 |
| Pioglitazone/Metformin (Actoplus met); |
| A New Indication for Gamma Hydroxybutyrate (Xyrem) in Narcolepsy; |
| Addendum: Hydrocodone Dosage; |
| Update: Influenza Resistance to Amantadine and Rimantadine |
|
|
|
| February 13; 48 (1228) : 13-16 |
| Treatment of Community-Associated MRSA Infections; |
| Nelarabine (Arranon) for T-Cell Acute Lymphoblastic Leukemia; |
| Phosphate Binders |
|
| February 27; 48 (1229) : 17-20 |
Abatacept (Orencia) for Rheumatoid
Arthritis; |
| Coenzyme Q10 |
|
|
|
| March 13; 48 (1230) : 21-24 |
| A Levalbuterol Metered-Dose Inhaler (Xopenex HFA); |
| Rosiglitazone/Glimepiride (Avandaryl) for Diabetes; |
| Hypo- and Hyperglycemia with Gatifloxacin (Tequin); |
| Exenatide (Byetta) for Weight Loss |
|
| March 27; 48 (1231) : 25-28 |
| Intra-Articular Injections for Osteoarthritis of the Knee; |
| Clobetasol Propionate (Clobex) Spray for Psoriasis |
|
|
|
| April 10; 48 (1232) : 29-32 |
| Clopidogrel (Plavix) Revisited; |
| Lenalidomide (Revlimid) for Anemia of Myelodysplastic Syndrome |
|
| April 24; 48 (1233) : 33-36 |
| Insulin Glulisine (Apidra): A New Rapid-Acting Insulin; |
| Rituximab (Rituxan) for Rheumatoid Arthritis; |
| Deferasirox (Exjade): A New Iron Chelator; |
| Telithromycin Hepatotoxicity |
|
|
|
| May 8; 48 (1234) : 37-40 |
| Raloxifene (Evista) for Breast Cancer Prevention in Postmenopausal Women; |
| Acupuncture; |
| Invader UGT1A1 Molecular Assay for Irinotecan Toxicity |
|
| May 22; 48 (1235) : 41-44 |
| Transdermal Selegiline (Emsam); |
| Anidulafungin (Eraxis) for Candida Infections; |
| Sodium Phosphate Colonoscopy Preps |
|
|
|
| June 5; 48 (1236) : 45-48 |
| Mumps Outbreak; |
| Ranolazine (Ranexa) for Chronic Angina; |
| Lubiprostone (Amitiza) for Chronic Constipation |
|
| June 19; 48 (1237) : 49-52 |
| Transdermal Methylphenidate (Daytrana) for ADHD; |
| Conivaptan (Vaprisol) for Hyponatremia; |
| One Drop or Two |
|
|
|
| July 3; 48 (1238) : 53-56 |
| Aspirin for Primary Prevention of Cardiovascular Disease (Revisited); |
| Insulin Detemir (Levemir), a New Long-Acting Insulin; |
| A Betamethasone-Calcipotriene Combination for Psoriasis |
|
| July 17; 48 (1239) : 57-60 |
| Inhaled Insulin (Exubera); |
| Fish Oil Supplements |
|
| July 31; 48 (1240) : 61-64 |
| RotaTeq: A New Oral Rotavirus Vaccine; |
| Naltrexone (Vivitrol) -- A Once Monthly Injection for Alcoholism; |
| In Brief: Calcium and Vitamin D Supplements |
|
|
|
| August 14/28; 48 (1241/1242) : 65-72 |
| A Human Papillomavirus Vaccine; |
| Varenicline (Chantix) for Tobacco Dependence; |
| Intravenous Ibandronate (Boniva); |
| VariZIG for Prophylaxis After Exposure to Varicella; |
| Automated External Defibrillators |
|
|
|
| September 11; 48 (1243) : 73-76 |
| Herpes Zoster Vaccine (Zostavax); |
| Darunavir (Prezista) for HIV Infection; |
| Plan B OTC; |
| Atorvastatin for Stroke Prevention; |
| Natalizumab (Tysabri) Returns |
|
| September 25; 48 (1244) : 77-80 |
| Three New Oral Contraceptives; |
| A Once-Daily Combination Tablet (Atripla) for HIV; |
| A Second Dose of Varicella Vaccine |
|
|
|
|
| November 6; 48 (1247) : 89-92 |
| Treatment of Clostridium difficile–Associated Disease (CDAD); |
| Decitabine (Dacogen) for Myelodysplastic Syndromes |
|
| November 20; 48 (1248) : 93-96 |
| Posaconazole (Noxafil) for Invasive Fungal Infections; |
| Extended-Release Minocycline (Solodyn) for Acne |
|
|
|
| December 4/18; 48 (1249/1250) : 97-104 |
| Rasagiline (Azilect) for Parkinson’s Disease; |
| The Stretta Procedure for GERD; |
| Intravenous Immunoglobulin (IVIG); |
| Nabilone (Cesamet) for Chemotherapy-Induced Nausea and Vomiting |
|
| 2006 Annual Index |
|
|
